By A Mystery Man Writer
Triple-negative breast cancer (TNBC) has a worse prognosis and remains the most challenging breast cancer subtype to treat. This is largely related to the heterogeneity of this disease and the lack of reliable oncological targets. In this review, we discuss the current standard-of-care treatment options for metastatic TNBC, including recent advances with the use of immunotherapy, PARP inhibitors and antibody-drug conjugates. This review also explores new agents and novel combinations arising in the field for the treatment of advanced TNBC.
Home Page: Annals of Oncology
Current Oncology, Free Full-Text
PDF) Efficacy of Second-Line Chemotherapy after a First-Line Triplet in Patients with Metastatic Colorectal Cancer
Current Oncology, Free Full-Text, bronstein méier resultado
Oncology 1971: Vol 25 Index : Free Download, Borrow, and Streaming
FREE WEBCAST] Expand Your Oncology Esthetics Knowledge
Home - American Society for Radiation Oncology (ASTRO)
Frontiers in Oncology
Radiation Oncology CME/CE Continuing Medical Education Courses
Textbook Of Radiation Oncology Principles And Practice: Rath
Current Oncology, Free Full-Text
Systematic Review Of The Management Of Brain Metastases, 50% OFF
Journal of Clinical Oncology